Category: Markets

Is The Era Of Stay-At-Home Stocks Over? Here’s Why Zoom, Peloton And Others Have Slumped In 2021

Some of the pandemic’s hottest stay-at-home stocks have undergone brutal sell-offs this year.

Vaccine Shares Soar As Dow Drops 1,000 Points, Oil Tumbles Over New Covid Variant Concerns

The Dow and oil prices fell by 2.8% and more than 10%, respectively, marking their worst days this year.

European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%

The European Medicines Agency said it could make a decision on the shot “within weeks.”

Billions Wiped From Covid Pharma Heavyweights—Including Moderna, Regeneron, Merck—As Pfizer’s Antiviral Pill Triggers Selloff

Pfizer jumped 8% Friday morning, while Moderna dropped 17.8%, Regeneron 6.2% and Merck 9%.

Moderna Crash Wipes Out Another $24 Billion After Supply Chain Issues Dent Covid Vaccine Sales

Now trading at their lowest level in three months, Moderna shares have struggled as experts question the long-term viability of the firm’s Covid-19 vaccine sales.

At Least 4 Groups Have Been Using PayPal And GoFundMe To Fundraise For Ivermectin, Covid Misinformation

Most online financing sites have rules prohibiting such groups, but they’re struggling to contend with an enduring network dedicated to false content.

Adrian Cheng Teams Up With Covid Testing Firm Prenetics For Greater Healthcare Accessibility

Cheng’s blank-check company Artisan Acquisition Corp. will merge with Prenetics in a deal that will value the biotech firm at $1.25 billion.

Blockchain’s Biggest Businesses: Forbes Blockchain 50 Call For 2022 Nominations

Over the first four years of the Forbes Blockchain 50, the list of billion-dollar companies making meaningful use of the technology popularized by bitcoin, has become a bellwether of institutional adoption.

Pfizer And Moderna Rally After FDA Grants Full Approval To Pfizer’s Covid-19 Vaccine

Pfizer climbed 4%, while its German vaccine partner, BioNTech, soared more than 10%.

Ping An, Alibaba, JD.com Healthcare Units Tumble As State Media Calls For Stepped Up Regulation

Chinese online healthcare stocks plunged more than 10% after a state-run newspaper called for greater supervision of prescription drugs sold on the internet, sparking fears that the government is preparing to introduce new regulations.